Biopta is able to assess vasoconstrictor activity of test drugs in human cerebral arteries; of particular interest to migraine and stroke research.
We are also working to develop models of blood-brain barrier function using our novel PM-1 instrument that allows perfusion of tiny blood vessels and measurements of vascular permeability.